{
    "2021-03-04": [
        [
            {
                "time": "",
                "original_text": "华鑫证券维持凯莱英推荐评级：国内CDMO龙头企业，服务能力持续提升",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "CDMO",
                        "龙头企业",
                        "服务能力",
                        "提升"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本概念股普遍下滑，公牛集团、凯莱英、泰格医药、金域医学、恩捷股份领跌",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "概念股",
                        "下滑",
                        "领跌",
                        "公牛集团",
                        "凯莱英",
                        "泰格医药",
                        "金域医学",
                        "恩捷股份"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "消费",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}